SCHEMBL18908820

SCHEMBL18908820

CCSc1cc(C(F)(F)F)cnc1-c1ccc(O)nn1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IL1B P01584 3/20 0.33
NPSR1 Q6W5P4 3/20 0.33
KDM4E B2RXH2 1/20 0.33
AGBL2 Q5U5Z8 1/20 0.33
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
ALDH1A1 P00352 3/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
DDR1 Q08345 3/20 0.31
POLB P06746 2/20 0.31
MAPT P10636 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
PKM P14618 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18908832 0.85 ALDH1A1 (0.35) NPSR1KDM4EALDH1A1DDR1POLB
SCHEMBL20233499 0.80 SMN1; SMN2 (0.33) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL30989630 0.80 SMN1; SMN2 (0.33) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL19491222 0.80 IL1B (0.43) IL1BNPSR1KDM4EMAPK1
SCHEMBL18908833 0.79 IL1B (0.40) IL1BMAPK1
SCHEMBL17459081 0.78 ALDH1A1 (0.35) KDM4EAGBL2ALDH1A1POLBPKM
SCHEMBL18908822 0.77 IL1B (0.39) IL1BKDM4EMEN1KMT2AMAPT
SCHEMBL18668542 0.74 PTGS2 (0.45) PTGS2
SCHEMBL21925146 0.73 NPC1 (0.44) KDM4EAGBL2ALDH1A1MEN1KMT2A
SCHEMBL17459082 0.73 DDR1 (0.35) NPSR1KDM4EALDH1A1DDR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3202761-B1 PYRIDAZINE COMPOUND SUMITOMO CHEMICAL CO (JP) 2022-03-16 EP disclosed
US-9924719-B2 Pyridazine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-27 US disclosed
US-9924719-B2 Pyridazine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-27 US disclosed
US-20170295787-A1 PYRIDAZINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-19 US disclosed
US-20170295787-A1 PYRIDAZINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-19 US disclosed
EP-3202761-A1 PYRIDAZINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2017-08-09 EP disclosed
WO-2017090655-A1 PEST CONTROL COMPOSITION AND USE THEREOF 住友化学株式会社 2017-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170295787-A1 PYRIDAZINE COMPOUND C5, C3AR1, H1-3 IL1B 2176/4885NPSR1 398/4885KDM4E 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.